TABLE 15.
Number of analytical results reported for TBBPA and TBBPA derivatives (TBBPA‐bME and TBBPA‐bDiBPrE) across different European countries and years (country of sampling; final cleaned data set).
| Compound | Country | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | Total | % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TBBPA | Denmark | 10 | 20 | 20 | 50 | 2% | ||||||||
| France | 172 | 209 | 191 | 183 | 185 | 1 | 941 | 34% | ||||||
| Germany | 47 | 47 | 2% | |||||||||||
| Ireland | 45 | 45 | 2% | |||||||||||
| Netherlands | 37 | 57 | 53 | 40 | 1 | 188 | 7% | |||||||
| Norway | 59 | 100 | 151 | 144 | 96 | 71 | 59 | 680 | 24% | |||||
| United Kingdom | 139 | 139 | 5% | |||||||||||
| TBBPA Total | Total | 37 | 219 | 348 | 258 | 360 | 345 | 152 | 144 | 96 | 71 | 60 | 2090 | 75% |
| TBBPA‐bDiBPrE | France | 168 | 174 | 4 | 346 | 12% | ||||||||
| TBBPA‐bME | France | 180 | 175 | 4 | 359 | 13% | ||||||||
| Total | 37 | 219 | 348 | 606 | 709 | 353 | 152 | 144 | 96 | 71 | 60 | 2795 | 100% | |
| % | 1% | 8% | 12% | 22% | 25% | 13% | 5% | 5% | 3% | 3% | 2% | 100% | – |